Boston Scientific Corp
BSX76.270USD
-1.370-1.76%
終値 02/06, 16:00（ET）15分遅れの株価
113.05B時価総額
38.96直近12ヶ月PER
詳細情報 Boston Scientific Corp 企業名
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Boston Scientific Corpの企業情報
企業コードBSX
会社名Boston Scientific Corp
上場日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)
従業員数53000
証券種類Ordinary Share
決算期末May 19
本社所在地300 Boston Scientific Way
都市MARLBOROUGH
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号01752-1234
電話番号15086834000
ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html
企業コードBSX
上場日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)
Boston Scientific Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-58824.00%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+2081.00%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+2081.00%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+562.00%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+2084.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-12891.00%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+2081.00%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-2901.00%
Ms. Miriam O' Sullivan
Ms. Miriam O' Sullivan
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-58824.00%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+2081.00%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+2081.00%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+562.00%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+2084.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-12891.00%
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Endoscopy
747.00M
14.75%
Peripheral Interventions
702.00M
13.86%
Urology
682.00M
13.46%
Electrophysiology
607.00M
11.98%
Watchman
470.00M
9.28%
他の
1.86B
36.66%
地域別USD
会社名
収益
比率
United States
3.29B
65.03%
Asia Pacific
802.00M
15.83%
EMEA (Europe, Middle East and Africa)
793.00M
15.66%
Latin America and Canada
175.00M
3.46%
事業別
地域別
事業別USD
会社名
収益
比率
Endoscopy
747.00M
14.75%
Peripheral Interventions
702.00M
13.86%
Urology
682.00M
13.46%
Electrophysiology
607.00M
11.98%
Watchman
470.00M
9.28%
他の
1.86B
36.66%
株主
更新時刻: Sun, Feb 1
更新時刻: Sun, Feb 1
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.37%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
他の
72.54%
株主統計
株主統計
比率
The Vanguard Group, Inc.
9.37%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
他の
72.54%
種類
株主統計
比率
Investment Advisor
51.52%
Investment Advisor/Hedge Fund
29.10%
Hedge Fund
4.91%
Pension Fund
2.90%
Research Firm
2.71%
Bank and Trust
1.98%
Sovereign Wealth Fund
1.58%
Family Office
0.29%
Private Equity
0.19%
他の
4.83%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
2858
1.40B
94.34%
-402.85K
2025Q3
2905
1.40B
94.56%
+9.92M
2025Q2
2818
1.39B
94.08%
+7.87M
2025Q1
2724
1.38B
93.98%
-8.23M
2024Q4
2559
1.38B
93.68%
+12.79M
2024Q3
2401
1.36B
94.13%
-3.01M
2024Q2
2325
1.37B
94.20%
+2.64M
2024Q1
2212
1.37B
95.15%
-32.63M
2023Q4
2153
1.38B
96.34%
-8.17M
2023Q3
2083
1.39B
95.41%
+17.41M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
137.57M
9.28%
+1.09M
+0.80%
Sep 30, 2025
Fidelity Management & Research Company LLC
90.62M
6.11%
-8.85M
-8.90%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
79.60M
5.37%
+1.41M
+1.81%
Sep 30, 2025
State Street Investment Management (US)
64.93M
4.38%
-266.30K
-0.41%
Sep 30, 2025
PRIMECAP Management Company
33.10M
2.23%
-1.56M
-4.50%
Sep 30, 2025
Geode Capital Management, L.L.C.
32.69M
2.21%
+265.55K
+0.82%
Sep 30, 2025
Capital World Investors
26.65M
1.8%
-1.88M
-6.58%
Sep 30, 2025
Managed Account Advisors LLC
23.16M
1.56%
+1.11M
+5.03%
Sep 30, 2025
The Bollard Group, LLC
19.73M
1.33%
-345.87K
-1.72%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
19.46M
1.31%
-275.11K
-1.39%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Mon, Dec 1
更新時刻: Mon, Dec 1
銘柄名
比率
iShares U.S. Medical Devices ETF
12.15%
Goldman Sachs Future Health Care Equity ETF
8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
3.87%
Tema Heart & Health ETF
3.66%
First Trust Bloomberg R&D Leaders ETF
3.14%
Parnassus Core Select ETF
3.1%
WisdomTree US AI Enhanced Value Fund
3.1%
Health Care Select Sector SPDR Fund
3.06%
Global X Aging Population ETF
2.99%
Proshares Ultra Health Care
2.95%
詳細を見る
iShares U.S. Medical Devices ETF
比率12.15%
Goldman Sachs Future Health Care Equity ETF
比率8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
比率3.87%
Tema Heart & Health ETF
比率3.66%
First Trust Bloomberg R&D Leaders ETF
比率3.14%
Parnassus Core Select ETF
比率3.1%
WisdomTree US AI Enhanced Value Fund
比率3.1%
Health Care Select Sector SPDR Fund
比率3.06%
Global X Aging Population ETF
比率2.99%
Proshares Ultra Health Care
比率2.95%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
